BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23086244)

  • 1. Prevention of severe acute pancreatitis with octreotide in obese patients: a prospective multi-center randomized controlled trial.
    Yang F; Wu H; Li Y; Li Z; Wang C; Yang J; Hu B; Huang Z; Ji R; Zhan X; Xie H; Wang L; Zhang M; Tang C
    Pancreas; 2012 Nov; 41(8):1206-12. PubMed ID: 23086244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose versus low-dose octreotide in the treatment of acute pancreatitis: a randomized controlled trial.
    Wang R; Yang F; Wu H; Wang Y; Huang Z; Hu B; Zhang M; Tang C
    Peptides; 2013 Feb; 40():57-64. PubMed ID: 23275042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response.
    Papachristou GI; Papachristou DJ; Avula H; Slivka A; Whitcomb DC
    Pancreatology; 2006; 6(4):279-85. PubMed ID: 16636600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
    Kisli E; Baser M; Aydin M; Guler O
    Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis.
    Nikou GC; Giamarellos-Bourboulis EJ; Grecka P; Toumpanakis Ch; Giannikopoulos G; Katsilambros N
    Hepatogastroenterology; 2004; 51(56):599-602. PubMed ID: 15086213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
    Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
    Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of the effect of pentoxifylline or octreotide on serum levels of TNF-alpha and IL-6 after endoscopic retrograde cholangiopancreatography.
    Kapetanos D; Christodoulou D; Chatzizisi O; Sigounas D; Vasiliou K; Stavropoulou E; Katodritou E; Kokozidis G; Kiriazis G; Kitis G; Tsianos E
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):529-33. PubMed ID: 19373973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis.
    Sempere L; Martinez J; de Madaria E; Lozano B; Sanchez-Paya J; Jover R; Perez-Mateo M
    Pancreatology; 2008; 8(3):257-64. PubMed ID: 18497538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of post-ERCP acute pancreatitis with octreotide].
    Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F
    G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
    Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
    Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis.
    Zhang XP; Tian H; Lai YH; Chen L; Zhang L; Cheng QH; Yan W; Li Y; Li QY; He Q; Wang F
    World J Gastroenterol; 2007 Oct; 13(38):5079-89. PubMed ID: 17876873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.